Cite
HARVARD Citation
Aldoss, I. et al. (2022). Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia. Cancer. 128 (3), pp. 529-535. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aldoss, I. et al. (2022). Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia. Cancer. 128 (3), pp. 529-535. [Online].